August

Blog Posts in August, 2017

Blog Home
  • Wells Fargo Still Fighting the Overdraft Case - Don't They Have Enough Problems!

    Posted By Golomb & Honik, P.C. || 9-Aug-2017

    Americans spend more money in bank overdraft fees than they do on clothes, eggs, books, newspapers and magazines combined! Banks make more than $14 billion – yes $14 billion – annually on overdraft fees. About one-third of that amount came from re-sequencing transactions from high to low so banks could make even more money. Financial institutions charge fees when a customer’s ...
    Continue Reading
  • Does Actemra Have the Same Risks as Vioxx?

    Posted By Golomb & Honik, P.C. || 8-Aug-2017

    Actemra is an injectable drug used for aduIts who suffer from rheumatoid arthritis, and the resulting chronic inflammation. Actemra, granted FDA approval in 2010, and manufactured by Roche and its Genentech unit, is believed to work by blocking inflammatory agents in the body. Because the more than 1.5 million Americans who take traditional prescription drug treatments for rheumatoid arthritis ...
    Continue Reading
  • Roundup Exposure Could Lead to Lymphoma

    Posted By Golomb & Honik, P.C. || 8-Aug-2017

    Roundup, the most widely used herbicide in the world and manufactured by Monsanto, now appears to significantly increase cancer risks. Monsanto, a St. Louis-based agribusiness giant, has faced numerous allegations through the years regarding Roundup, which has a primary ingredient of glyphosate—a “ probable human carcinogen.” In 2015, the International Agency for Research on ...
    Continue Reading
  • Drugmakers Agree to $300M Settlement in MDL Over Hypertension Medication Benicar

    Posted By Golomb & Honik, P.C. || 2-Aug-2017

    Drugmakers Daiichi Sankyo and Forest Laboratories have agreed to a $300 million settlement of multidistrict litigation by users of hypertension drug Benicar who linked their cases of severe diarrhea to use of the drug. Read more here.
    Continue Reading
  • 4 results found. Viewing page 1 of 1.